S&P also affirmed its “AA+” rating on NMHC’s series 2013 bonds and Chicago-based Northwestern Memorial Hospital’s series 2009A and 2009B bonds. S&P affirmed its “AA+/A-1+” rating on Northwestern Memorial Hospital’s series 2002C bonds.
“The ratings reflect our view of NMHC’s strong operations for the first nine months of fiscal 2016,” said S&P analyst Brian Williamson.
The outlook is stable, reflecting S&P’s opinion that NMHC will maintain strong operations as its leadership continues to maintain the expense base while investing in other facilities and affiliations.
More articles on healthcare finance:
University Medical Center of El Paso faces $17M deficit
RCM Tip of the Day: Focus on patient experience
BPCI hospitals drove down Medicare payments for lower extremity joint replacement by $1,166
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
